In
endemic areas infection with hepatitis B virus is a common cause of
chronic liver disease in childhood. High levels of viral
replication and mild ALT abnormalities are the rule in children
infected perinatally and many of them are likely to maintain viral
replication through their youth. Conversely about 90% of children
infected later in life clear HBeAg and achieve sustained remission
of liver disease before reaching adulthood. The eventual outcome of
infection and disease in these patients remains unpredictable as
reactivation of liver damage and viral replication may occur after
several years of sustained remission. Cirrhosis is a rare and early
complication of chronic HBV infection in children, and a risk
factor for hepatocellular carcinoma. IFN therapy can accelerate HBV
DNA clearance, improving the spontaneous anti-HBe seroconversion
rate in Caucasian children by two to three times. Hepatitis delta
is the most severe form of chronic viral hepatitis in childhood.
Cirrhosis can be diagnosed in up to 26% of patients at
presentation, and few cases respond to IFN therapy.
Hepatitis C is relatively rare in children.
Before the discovery of HCV, blood transfusions were the most
common source of infection. Hepatitis C is usually a mild,
asymptomatic disease in otherwise healthy children, but has a poor
propensity to spontaneous remission over the years. For this
reason, and based on the experience in adults, IFN treatment is now
being evaluated.
Author: Bortolotti F, Clinica Medica II,
University of Padova, Italy. Source: Baillieres Clin Gastroenterol
10: 185-206 (1996)